← Open Payments lookup

JANNA CRAYCHEE: Open Payments

NPI 1780233411 · CORONADO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,151 in 55 payments from 14 companies in 2025. Trend: 2023 $1,584 · 2024 $1,581 · 2025 $2,151

Food & beverage: $1,571Travel & lodging: $581
CompanyPaymentsAmount
Boston Scientific Corporation5$941
Takeda Pharmaceuticals U.S.A., Inc.9$253
ABBVIE INC.9$161
Janssen Biotech, Inc.6$121
Gilead Sciences, Inc.1$118
Regeneron Healthcare Solutions, Inc.4$109
Madrigal Pharmaceuticals5$99
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$92
Celltrion USA Inc.3$71
Phathom Pharmaceuticals, Inc.3$60

Products named: General - Therapies, ENTYVIO, LINZESS, DUPIXENT, TREMFYA, REZDIFFRA, XIFAXAN, VEGZELMA.

Industry payments across CA — which companies pay providers there.